Zymeworks (ZYME) Confirms Receipt of Unsolicited, Non-Binding Proposal from All Blue Falcons
Zymeworks Inc. (ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, confirmed it has received an unsolicited, non-binding proposal from All Blue Falcons FZE (“ABF”)
Read More